Conversion to proliferation signal inhibitorsbased immunosuppressive regimen in kidney transplantation: To whom and when?

Transplantation Proceedings

Volumn 43, Issue 3, 2011, Pages 837-840

  Sahin, S ^a   Gurkan A ^a   Uyar, M ^a   Dheir, H ^a   Turun, V ^a   Varilsuha, C ^b   Kaar S ^c  

^a Gaziosmanpasa Hospital   (Turkey)

^b Medicana Hospitals Camlica   (Turkey)

^c MEDICAL PARK HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; EVEROLIMUS; RAPAMYCIN;

ACNE; ADULT; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SUBSTITUTION; FEMALE; GASTROINTESTINAL TOXICITY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CELL PROLIFERATION; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 79954549962     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.01.097     Document Type: Conference Paper

References (17)

1. H.U. Meier-Kriesche, J.D. Schold, and T.R. Srinivas Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era Am J Transplant 4 2004 378
2. G. Guerra, T.R. Srinivas, and H.U. Meier-Kriesche Calcineurin inhibitorfree immunosuppression in kidney transplantation Transpl Int 20 2007 813
3. S.M. Flechner, J. Kobashigawa, and G. Klintmalm Calcineurin inhibitorsparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity Clin Transplant 22 2008 1
4. J. Pascual Everolimus in clinical practice renal transplantation Nephrol Dial Transplant suppl 3 2006 18
5. A.V. Mulay, N. Hussain, and D. Fergusson Calcineurin inhibitor withdrawal from sirolimus based therapy in kidney transplantation: a systematic review of randomized trials Am J Transplant 5 2005 1748
6. G. Stallone, B. Infante, and A. Schena Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients J Am Soc Nephrol 16 2005 3755
7. B.D. Kahan Rapamune US Study Group Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicenter study Lancet 356 2000 194
8. G. Ciancio, G.W. Burke, and J.J. Gaynor A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporine/ sirolimus in renal transplantation: three-year analysis Transplantation 81 2006 845
9. J.M. Grinyo, and J.M. Cruzado Mycophenolate mofetil and sirolimus combination in renal transplantation Am J Transplant 6 2006 1991
10. M. Pascual, J. Curtis, and F.L. Delmonico A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation Transplantation 75 2003 1501
11. E. Morelon, and H. Kreis Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience Transplant Proc 35 2003 52
12. E. Letavernier, M.N. Peraldi, and A. Pariente Proteinuria following a switch from calcineurin inhibitors to sirolimus Transplantation 80 2005 1198
13. F. Diekmann, K. Budde, and F. Oppenheimer Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction Am J Transplant 4 2004 1869
14. G. Loriga, M. Ciccarese, and R.P. Pala De novo everolimus-based therapy in renal transplant recipients: Effect on proteinuria and renal prognosis Transplant Proc 42 2010 1297
15. T. van Gelder, C.G. ter Meulen, and R. Hene Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil Transplantation 75 2003 788
16. J.M. Campistol, J.W. de Fijter, and S.M. Flechner mTOR inhibitor-associated dermatologic and mucosal problems Clin Transplant 24 2010 149
17. B. Nahsan, J. Curtis, C. Ponticelli 156 Study Group Everolimus and reduced exposure cyclosporine in de novo renal-transplant recipients: a three year phase II, randomized, multicenter, open-label study Transplantation 78 2004 1332